Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Opthea Announces Being Granted Chinese Patent Covering OPT-302

27 Oct 2021  |  08:16:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Opthea Granted Chinese Patent Covering OPT-302

Opthea announced the grant of Chinese Patent Number (CN) 106414487 B covering OPT302, its soluble VEGFR-3 trap molecule currently being investigated in two global Phase 3 registrational clinical trials, ShORE (Study of OPT-302 in combination with Ranibizumab) and COAST (Combination OPT-302 with Aflibercept Study). The patent granted in the name of its wholly-owned subsidiary, Vegenics.

Please click here for full details

See more ASX300 News Announcements